# A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab

> **NCT05388474** · — · ACTIVE_NOT_RECRUITING · sponsor: **Theratechnologies** · enrollment: 168 (actual)

## Conditions studied

- HIV Infections
- Multi-Antiviral Resistance

## Interventions

- **OTHER:** No ibalizumab or Pre-ibalizumab treatment
- **BIOLOGICAL:** On ibalizumab treatment

## Key facts

- **NCT ID:** NCT05388474
- **Lead sponsor:** Theratechnologies
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-03-22
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2026-01-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05388474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05388474, "A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05388474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*